The FDA changed the trial designs last year or the year before?? I don't remember. Many trials are now allowed to be set up as a P2/P2b so the trial can simply roll into the P2b2. Anyone want to add to this is fine by me. And with a lot of the so called red tape circumvented in todays time they may even be more flexible.

Anyway, we'll see what happens.